Literature DB >> 19995813

Neuraminidase inhibitors--the story behind the Cochrane review.

Peter Doshi1.   

Abstract

Entities:  

Mesh:

Substances:

Year:  2009        PMID: 19995813     DOI: 10.1136/bmj.b5164

Source DB:  PubMed          Journal:  BMJ        ISSN: 0959-8138


× No keyword cloud information.
  22 in total

1.  [Influenza : clinical symptoms, diagnostics and therapy].

Authors:  G G U Rohde
Journal:  Internist (Berl)       Date:  2011-09       Impact factor: 0.743

2.  Oseltamivir and risk of lower respiratory tract complications in patients with flu symptoms: a meta-analysis of eleven randomized clinical trials.

Authors:  Miguel A Hernán; Marc Lipsitch
Journal:  Clin Infect Dis       Date:  2011-06-15       Impact factor: 9.079

3.  Searching ClinicalTrials.gov and the International Clinical Trials Registry Platform to inform systematic reviews: what are the optimal search approaches?

Authors:  Julie M Glanville; Steven Duffy; Rachael McCool; Danielle Varley
Journal:  J Med Libr Assoc       Date:  2014-07

4.  The importance of clinical trial data sharing: toward more open science.

Authors:  Joseph S Ross; Richard Lehman; Cary P Gross
Journal:  Circ Cardiovasc Qual Outcomes       Date:  2012-03-01

Review 5.  Neuraminidase inhibitors for preventing and treating influenza in healthy adults: systematic review and meta-analysis.

Authors:  Tom Jefferson; Mark Jones; Peter Doshi; Chris Del Mar
Journal:  BMJ       Date:  2009-12-08

6.  Industry influence in evidence production.

Authors:  Adam G Dunn; Florence T Bourgeois; Enrico Coiera
Journal:  J Epidemiol Community Health       Date:  2013-01-30       Impact factor: 3.710

7.  The imperative to share clinical study reports: recommendations from the Tamiflu experience.

Authors:  Peter Doshi; Tom Jefferson; Chris Del Mar
Journal:  PLoS Med       Date:  2012-04-10       Impact factor: 11.069

8.  Lack of proportionality. Seven specifications of public interest that override post-approval commercial interests on limited access to clinical data.

Authors:  Daniel Strech; Jasper Littmann
Journal:  Trials       Date:  2012-07-02       Impact factor: 2.279

9.  Access to regulatory data from the European Medicines Agency: the times they are a-changing.

Authors:  Beate Wieseler; Natalie McGauran; Michaela F Kerekes; Thomas Kaiser
Journal:  Syst Rev       Date:  2012-10-30

Review 10.  The value of neuraminidase inhibitors for the prevention and treatment of seasonal influenza: a systematic review of systematic reviews.

Authors:  Barbara Michiels; Karolien Van Puyenbroeck; Veronique Verhoeven; Etienne Vermeire; Samuel Coenen
Journal:  PLoS One       Date:  2013-04-02       Impact factor: 3.240

View more

北京卡尤迪生物科技股份有限公司 © 2022-2023.